 - If subject is already on antimalarial medication at time of study entry, no more than 3 doses of either generic AL or brand Coartem either standard tablet or the dispersible formulation may be given prior to study entry. Subjects may have received only the first, second, andor third dose as a different AL formulation from the study formulation of Coartem Dispersible. However, the actual dose of artemether and lumefantrine that has been administered MUST be the same as that stipulated by the protocol. 